Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

Taking Advantage of Phage Technologies (TAPT) to Facilitate Phage Therapy While Reducing the Use of Antibiotics in the Management of Cystic Fibrosis (CF)

Not Applicable

Not yet recruiting

Conditions: Klebsiella Pneumoniae Infection
E Coli Infections
Achromobacter
Cystic Fibrosis (CF)
Stenotrophomonas Maltophilia Infection
Staphylococcus Aureus Infection

First Posted Date: 2025-07-02

Last Posted Date: 2025-07-02

Lead Sponsor: University of California, San Diego

Target Recruit Count: 30

Registration Number: NCT07048704

Pain Related to Local Anesthetic Administration for Nexplanon Placement

Not Applicable

Not yet recruiting

Conditions: Pain Related to Local Anesthetic Administration for Nexplanon Placement

First Posted Date: 2025-06-06

Last Posted Date: 2025-06-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 68

Registration Number: NCT07008222

Neural Control and Mechanosensation in Spine Muscle

Not yet recruiting

Conditions: Low Back Pain and Core Muscle
Disc Herniation

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: University of California, San Diego

Target Recruit Count: 120

Registration Number: NCT07003802

Locations: 🇺🇸
UC San Diego, La Jolla, California, United States

The Mechanism Versus PPI Trial

Phase 4

Conditions: Laryngopharyngeal Reflux
Cough
Throat Clearing
Dysphonia
Reflux

Interventions: Drug: Omeprazole 40 MG
Behavioral: Laryngeal Recalibration Therapy
Behavioral: GERD Lifestyle Recommendations

First Posted Date: 2025-05-31

Last Posted Date: 2025-06-10

Lead Sponsor: University of California, San Diego

Target Recruit Count: 160

Registration Number: NCT06999577

Locations: 🇺🇸
University of California San Diego, San Deigo, California, United States

Liposomal Bupivacaine Versus Continuous Peripheral Nerve Blocks for Analgesia Following Ankle Surgery

Phase 4

Conditions: Moderate-to-severely Painful Ankle Surgery

Interventions: Drug: Popliteal nerve block including liposomal bupivacaine
Drug: Popliteal nerve block with exclusively unencapsulated bupivacaine
Drug: Adductor canal nerve block including liposomal bupivacaine
Drug: Adductor canal nerve block with exclusively unencapsulated bupivacaine
Drug: Continuous popliteal nerve block with normal saline
Drug: Continuous popliteal nerve block with unencapsulated bupivacaine

First Posted Date: 2025-05-29

Last Posted Date: 2025-07-02

Lead Sponsor: University of California, San Diego

Target Recruit Count: 140

Registration Number: NCT06995352

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

Labor Education to Reduce Postpartum Traumatic Stress

Not Applicable

Not yet recruiting

Conditions: Postpartum Complication
Posttraumatic Stress Symptoms

First Posted Date: 2025-05-28

Last Posted Date: 2025-06-03

Lead Sponsor: University of California, San Diego

Target Recruit Count: 400

Registration Number: NCT06992791

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Cancer

First Posted Date: 2025-05-25

Last Posted Date: 2025-06-29

Lead Sponsor: University of California, San Diego

Target Recruit Count: 150

Registration Number: NCT06990542

Locations: 🇺🇸
University of California, San Diego, La Jolla, California, United States

Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial

Phase 2

Recruiting

Conditions: Type 1 Diabetes

Interventions: Drug: Acetazolamide
Drug: Placebo

First Posted Date: 2025-05-20

Last Posted Date: 2025-06-17

Lead Sponsor: University of California, San Diego

Target Recruit Count: 25

Registration Number: NCT06981234

Locations: 🇺🇸
UC San Diego Altman Clinical & Translational Research Institute, La Jolla, California, United States

Empathy Through Pain Control: Buffered Compared to Unbuffered 1% Lidocaine During IUD Placement

Not Applicable

Not yet recruiting

Conditions: Contraception
Pain, Acute
Anesthesia, Local

Interventions: Drug: Buffered Lidocaine
Drug: Lidocaine 1% Injectable Solution

First Posted Date: 2025-05-15

Last Posted Date: 2025-05-15

Lead Sponsor: University of California, San Diego

Target Recruit Count: 68

Registration Number: NCT06974019

Empathy Through Pain Control: Lidocaine Gel vs. Placebo Prior to IUD Placement

Not Applicable

Not yet recruiting

Conditions: Contraception
Pain, Acute
Anesthesia, Local

Interventions: Drug: Xylocaine jelly 2%
Drug: Surgilube

First Posted Date: 2025-05-15

Last Posted Date: 2025-05-15

Lead Sponsor: University of California, San Diego

Target Recruit Count: 68

Registration Number: NCT06974032

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy